Key facts
- Deep Track Capital, LP filed SCHEDULE 13G/A for CorMedix Inc. Common stock, $0.001 par value (CRMD).
- Disclosed ownership: 7.9%.
- Date of event: 31 Mar 2026.
Deep Track Capital, LP - 31 Mar 2026 SCHEDULE 13G/A Report for CorMedix Inc. Common stock, $0.001 par value (CRMD)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- CRMD
- Shares outstanding
- 79,018,589 shares
- Disclosed Ownership
- 6,274,076 shares
- Ownership
- 7.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2026, 08:39:47 UTC
- Date of event
- 31 Mar 2026
- Previous filing
- 01 Dec 2025
- SEC
- View on sec.gov
Key filing fact
Deep Track Capital, LP disclosed 7.9% ownership in CorMedix Inc. Common stock, $0.001 par value (CRMD) on 31 Mar 2026.
Change
- Previous schedule filing date: 01 Dec 2025.
- Current filing was accepted on 15 May 2026, 08:39.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 7.9% | 6,274,076 | 0 | 6,274,076 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 7.9% | 6,274,076 | 0 | 6,274,076 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 7.9% | 6,274,076 | 0 | 6,274,076 | /s/ David Kroin | David Kroin |
CIK / CUSIP context first